ArriVent BioPharma, Inc. (AVBP) › Total AssetsArriVent BioPharma, Inc. (AVBP) — Total AssetsAnnual figures by fiscal year, from SEC filings.2023: $163.10M2024: $274.94M2025: $333.17M$333.17M2023Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$333.17M+21.2%2024$274.94M+68.6%2023$163.10M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share